VanEck Biotech Financials
| BBH Etf | USD 167.03 1.59 0.96% |
Net Expense Ratio 0.0035 | 3 y Sharp Ratio (0.39) |
VanEck |
The data published in VanEck Biotech's official financial statements typically reflect VanEck Biotech's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving VanEck Biotech's quantitative information. For example, before you start analyzing numbers published by VanEck accountants, it's essential to understand VanEck Biotech's liquidity, profitability, and earnings quality within the context of the VanEck space in which it operates.
VanEck Biotech Etf Summary
VanEck Biotech competes with VanEck Pharmaceutical, VanEck Retail, First Trust, Invesco Dynamic, and IShares Biotechnology. The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States.| Instrument | USA Etf View All |
| Exchange | NASDAQ Exchange |
| ISIN | US92189F7261 |
| CUSIP | 92189F726 57060U183 09067D201 |
| Region | Global |
| Investment Issuer | Van Eck |
| Etf Family | VanEck |
| Fund Category | Sector |
| Portfolio Concentration | Health Care |
| Benchmark | Dow Jones Industrial |
| Phone | NA |
| Currency | USD - US Dollar |
VanEck Biotech Key Financial Ratios
VanEck Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VanEck Biotech's current stock value. Our valuation model uses many indicators to compare VanEck Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VanEck Biotech competition to find correlations between indicators driving VanEck Biotech's intrinsic value. More Info.VanEck Biotech ETF is second largest ETF in price to earning as compared to similar ETFs. It is third largest ETF in price to book as compared to similar ETFs fabricating about 0.16 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for VanEck Biotech ETF is roughly 6.45 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VanEck Biotech's earnings, one of the primary drivers of an investment's value.VanEck Biotech ETF Systematic Risk
VanEck Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. VanEck Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on VanEck Biotech ETF correlated with the market. If Beta is less than 0 VanEck Biotech generally moves in the opposite direction as compared to the market. If VanEck Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one VanEck Biotech ETF is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of VanEck Biotech is generally in the same direction as the market. If Beta > 1 VanEck Biotech moves generally in the same direction as, but more than the movement of the benchmark.
About VanEck Biotech Financials
What exactly are VanEck Biotech Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include VanEck Biotech's income statement, its balance sheet, and the statement of cash flows. Potential VanEck Biotech investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although VanEck Biotech investors may use each financial statement separately, they are all related. The changes in VanEck Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VanEck Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.VanEck Biotech Thematic Clasifications
VanEck Biotech ETF is part of several thematic ideas from Sector ETFs to Health Care ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasVanEck Biotech November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of VanEck Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of VanEck Biotech ETF. We use our internally-developed statistical techniques to arrive at the intrinsic value of VanEck Biotech ETF based on widely used predictive technical indicators. In general, we focus on analyzing VanEck Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build VanEck Biotech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 6.02 | |||
| Value At Risk | (1.87) | |||
| Potential Upside | 1.23 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.